Chairman, Chief Executive Officer and Executive Director
He joined Green Cross Corporation (now Mitsubishi Tanabe Pharma Corporation) and served as Manager of the Planning Section of the Sales Planning Department, Manager of the President’s Office, etc. until he left the company. In 2001, he established Mebix, Inc., while he was a research fellow at the Graduate School of Medicine, the University of Tokyo in the same year. In 2005, Mebix Corporation was listed on the Tokyo Stock Exchange Mothers. He was appointed as Chairman and Representative Director of Sogo Rinsho Medefi Co., Ltd. in 2013 and Vice President of Sogo Rinsho Holdings Co., Ltd. in 2014 respectively. In the EPS Group, he served as Vice President of the SMO Segment, and then as Managing Corporate Officer, Deputy General Manager of the Business Headquarters of EPS Holdings, Inc. and Representative Director and CEO of EPS Innovative Medicine (Japan) Co., Ltd.
Managing Director, Chief Operating Officer and Executive Director
He used to engage in trade transactions between Japan-US, Japan-Europe and Japan-Asia for life science-related materials at a trading company. He joined the EPS Group in 2002 and has served as the representative of a life science materials manufacturing company in the Philippines and as the representative director of EPS Ekishin Co., Ltd., which is engaged in business in China.
He has been participating in EPS Creative Health Technology Group Limited from the planning stage, and will serve as COO from 2022.
Chief Strategy Officer and Executive Director
He obtained a BSc degree from Peking University, and has extensive experience in corporate planning and management for companies in China. Other than considerable experience in corporate planning and management in China, he has held senior management positions in several Chinese multinational technology companies.
Prior to 2009, he served as vice president of Beijing Securities in Hong Kong, an expert member of the National Network Culture Standardization Technical Committee of China's Ministry of Culture, and deputy researcher at the National Cultural Industry Innovation Research Base of Peking University’s Institute of Cultural Industries, where he participated in government-led industrial projects. In 2010, he was a senior consultant in Beijing Yu Sheng Tang, contributing to development of the company’s anti-influenza specialty Chinese herbal medicine “Jinhua Qinggan” and listing the company on the Hong Kong Stock Exchange . From 2011 to 2012, he was a senior consultant for Xinhua News Agency, supporting the company’s listing on the Hong Kong Stock Exchange. From 2014 to 2017, he served as Managing Director, Chairman of the Board and Senior Consultant at Yingsheng Science Co., Ltd. and was a major shareholder during the period. He participated in the establishment of Jianhao Fund Management Company in 2018, oversaw investing in Japanese companies and dedicated to listing of the company on the Hong Kong Stock Exchange.
Chief Financial Officer and Executive Director
He was engaged in financial accounting work at KPMG Peat Marwick in Japan from 1995 to 2001. From 2001 to 2016, he was Finance Department Manager and Overseas Business Administration Manager of Sun Japan Co., Ltd. From 2016 to 2018, he was Corporate Planning Manager of the General Headquarters at SRA, Inc. He joined EPS Ekishin Co., Ltd. in 2018, serving as Corporate Officer and General Manager of the Finance Department, and as Manager of the EPSHD Finance Office.
CMO and Executive Director
In 1992, he joined Mitsubishi Bank (present Mitsubishi UFJ Bank). He has been engaged in corporate finance business in the bank for 30 years until 2022. During this period, he served as a senior manager in Japan Business Development headquarters, Shanghai branch in China and other places, and as a deputy general manager in MUFG Bank (Malaysia).
He joined the EPS Holdings Company in 2022 as the chief manager of the Management Support headquarters. In the same year, he became the CMO of EPS Creative Health Technology Group.
In 1981, he studied abroad at the Department of Genetics (now Molecular Genetics Laboratory) at Okayama University as a Chinese government-sponsored international student and obtained a master’s degree in science. Returning to China, he engaged in trade, investment, and technology exchange projects between Japan and China for 20 years at the China Council for the Promotion of International Trade (CCPIT). He retired from the Council after his last job as its general representative in Japan. In 2008, he joined Ekishin (China) Co., Ltd., the regional headquarters of EPS in China, was engaged in the establishment and business development of Ekishin (China) and served as General Manager and Deputy Chairman. In 2018, he was appointed as an Corporate Officer and counselor of EPS Holdings Co., Ltd., mainly in management support, and in charge of the management department of EPS Creative Health Technology Group Limited. He has experience in social activities as Vice President of the China Enterprises Association (Japan) and Executive Director of the Chinese Chamber of Commerce in Japan.
He graduated from the Faculty of Medicine, the University of Tokyo in 1984 with a doctor’s license. He has worked as a physician at the University of Tokyo Hospital, and has experience as a court physician to the board of chamberlains at the Imperial Household Agency. His career includes Associate Professor and Medical Information Manager of the Department of Cardiology, Tokai University Hachioji Hospital and an external director of EPS Holdings Co., Ltd.. He then worked as Director of Tokyo Midtown Clinic, Managing Director of The Midtown Clinic Medical Corporation, and an independent director of EPS Creative Health Technology Group Limited.
He holds a Bachelor of Arts degree from the University of British Columbia and has over 25 years of experience in real estate investment, development and corporate lending. He joined Sunwah Kingsway Capital Holdings Limited as an executive officer in 2000, and since 2010 he has been CEO of the company. Since 2021, he has been an independent director of EPS Creative Health Technology Group Limited.
He graduated from the Faculty of Business Administration, the Chinese University of Hong Kong in 1989. He took a Master of Business Administration degree from the University of Manchester in 2003. In the same year, he became a member of the Association of Hong Kong Accountants. For the next 20 years, he served as executive director, financial director, and secretary for a number of listed companies.
In November 2001, he became an independent external director of Eagle Nice (International) Holdings Limited, an executive director of PINE Technology Holdings Limited in June 2017, an independent external director of Wai Chun Mining Industry Group in November 2020, and a company secretary of PINE Technology Holdings Limited in July 2017. Since 2021, he has been an independent director of EPS Creative Health Technology Group Limited.